Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. R. Capeding · SciRah

Researcher profile · Semantic Scholar

M. R. Capeding

Share profile

M. R. Capeding — researcher profile on SciRah

h-index: 20
Works: 58
Citations: 3,474

Most-cited papers

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
S. R. Hadinegoro, J. Arredondo-García, M. R. Capeding, C. Deseda +20 more
2015New England Journal of Medicine1,020 citations Open access
Semantic Scholar
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.
M. R. Capeding, N. H. Tran, S. R. Hadinegoro, H. I. Ismail +19 more
2014The Lancet895 citations
Semantic Scholar
Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children
B. Forrest, M. Pride, Andrew J. Dunning, M. R. Capeding +5 more
2008Clinical and Vaccine Immunology266 citations Open access
Semantic Scholar
Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia
John S. Tam, M. R. Capeding, L. Lum, T. Chotpitayasunondh +13 more
2007The Pediatric Infectious Disease Journal173 citations
Semantic Scholar
Dengue and Other Common Causes of Acute Febrile Illness in Asia: An Active Surveillance Study in Children
M. R. Capeding, M. N. Chua, S. R. Hadinegoro, I. I. Hussain +12 more
2013PLoS Neglected Tropical Diseases139 citations Open access
Semantic Scholar
Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
Z. Bhutta, M. R. Capeding, A. Bavdekar, E. Marchetti +14 more
2014Lancet. Infectious Diseases (Print)126 citations
Semantic Scholar
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
K. Hardt, A. Vandebosch, J. Sadoff, Mathieu le Gars +284 more
2022Lancet. Infectious Diseases (Print)65 citations Open access
Semantic Scholar
Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study
A. Chuansumrit, Somporn Wangruangsatid, Yujinda Lektrakul, M. Chua +2 more
2005Blood Coagulation and Fibrinolysis63 citations
Semantic Scholar
Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial
J. Nealon, A. Taurel, M. R. Capeding, N. H. Tran +11 more
2016PLoS Neglected Tropical Diseases52 citations Open access
Semantic Scholar
Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries
T. Wartel, Ari Prayitno, S. R. Hadinegoro, M. R. Capeding +6 more
2017Asia-Pacific journal of public health50 citations
Semantic Scholar
Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.
H. Nohynek, L. Gustafsson, M. R. Capeding, H. Käyhty +3 more
1999The Pediatric Infectious Disease Journal47 citations
Semantic Scholar
Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial
Emmanuel Feroldi, C. Pancharoen, P. Kosalaraksa, V. Watanaveeradej +5 more
2012Human Vaccines & Immunotherapeutics42 citations Open access
Semantic Scholar
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children
M. R. Capeding, S. Teshome, T. Saluja, Khalid Ali Syed +18 more
2018Vaccine41 citations Open access
Semantic Scholar
Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
Sai-Kit Lam, D. Burke, M. R. Capeding, C. K. Chong +23 more
2011Vaccine33 citations Open access
Semantic Scholar
Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children
Emmanuel Feroldi, M. R. Capeding, Mark J. Boaz, Sophia Gailhardou +2 more
2013Human Vaccines & Immunotherapeutics31 citations Open access
Semantic Scholar
Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries
J. Nealon, A. Taurel, S. Yoksan, A. Moureau +7 more
2018Journal of Infectious Diseases30 citations Open access
Semantic Scholar
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
R. Forrat, G. Dayan, C. Diazgranados, M. Bonaparte +19 more
2021Clinical Infectious Diseases25 citations Open access
Semantic Scholar
Immunogenicity and safety of a DTaP-IPV//PRP~T combination vaccine given with hepatitis B vaccine: a randomized open-label trial
M. R. Capeding, Josefina Cadorna-Carlos, May Book-Montellano, E. Ortiz
200823 citations Open access
Semantic Scholar
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
M. R. Capeding, A. Sil, B. Tadesse, T. Saluja +21 more
2020EClinicalMedicine22 citations Open access
Semantic Scholar
Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report
M. R. Capeding, E. Alberto, A. Sil, T. Saluja +17 more
2020Vaccine21 citations Open access
Semantic Scholar
Immunogenicity and safety of a tetravalent dengue vaccine during a five-year follow-up period
M. R. Capeding, Thelma M. Laot, Mark J. Boaz, T. Wartel +1 more
201518 citations Open access
Semantic Scholar
Factors influencing healthcare utilization among children with pneumonia in Muntinlupa City, the Philippines.
S. Kim, M. R. Capeding, P. Kilgore
2014Southeast Asian Journal of Tropical Medicine and Public Health18 citations
Semantic Scholar
Estimating the annual dengue force of infection from the age of reporting primary infections across urban centres in endemic countries
Joseph R. Biggs, A. K. Sy, Katharine Sherratt, O. Brady +13 more
2021BMC Medicine15 citations Open access
Semantic Scholar
Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study.
T. Nolan, T. Chotpitayasunondh, M. R. Capeding, Simon Carson +4 more
2016Vaccine15 citations Open access
Semantic Scholar
First Experience of Concomitant Vaccination Against Dengue and MMR in Toddlers
D. Crevat, Job D. Brion, Sophia Gailhardou, Thelma M. Laot +1 more
2015The Pediatric Infectious Disease Journal15 citations Open access
Semantic Scholar
Prospective Surveillance Study of Invasive Pneumococcal Disease Among Urban Children in the Philippines
M. R. Capeding, L. Bravo, J. Santos, P. Kilgore +5 more
2013The Pediatric Infectious Disease Journal15 citations
Semantic Scholar
Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study
M. R. Capeding, G. D. Gomez-Go, Peninnah Oberdorfer, C. Borja-Tabora +8 more
2020Journal of Infectious Diseases14 citations Open access
Semantic Scholar
Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
M. R. Capeding, E. Alberto, A. Bouckenooghe, Thelma M. Laot +4 more
2018Journal of Infectious Diseases13 citations Open access
Semantic Scholar
Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study
U. Choi, Ki Hwan Kim, H. Cho, Dong Ho Kim +10 more
2023Vaccines12 citations Open access
Semantic Scholar
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.
D. Coronel-MartÍnez, Juliana Park, Eduardo López-Medina, M. R. Capeding +16 more
2020Lancet. Infectious Diseases (Print)12 citations
Semantic Scholar
Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization
P. Kosalaraksa, V. Watanaveeradej, C. Pancharoen, M. R. Capeding +2 more
2017The Pediatric Infectious Disease Journal12 citations
Semantic Scholar
Combining rapid diagnostic tests to estimate primary and post-primary dengue immune status at the point of care
Joseph R. Biggs, A. K. Sy, James Ashall, Marsha S. Santoso +29 more
2022PLoS Neglected Tropical Diseases11 citations Open access
Semantic Scholar
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose
M. R. Capeding, B. Tadesse, A. Sil, E. Alberto +16 more
2022npj Vaccines11 citations Open access
Semantic Scholar
A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines
Joseph R. Biggs, A. K. Sy, O. Brady, A. Kucharski +21 more
2020BMC Medicine11 citations Open access
Semantic Scholar
Controversy and debate on dengue vaccine series-paper 2: response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs.
S. R. Hadinegoro, J. Arredondo-García, M. R. Capeding, S. Pallardy +2 more
2018Journal of Clinical Epidemiology11 citations
Semantic Scholar
A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies.
B. Quiambao, Ronald Allan Payumo, Camilo C Roa, C. Borja-Tabora +10 more
2024Vaccine10 citations
Semantic Scholar
Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease
Chloé Pasin, M. E. Halloran, P. Gilbert, Edith Langevin +8 more
2018PLoS ONE10 citations Open access
Semantic Scholar
Serological Evidence of Widespread Zika Transmission across the Philippines
Joseph R. Biggs, A. K. Sy, O. Brady, A. Kucharski +14 more
2021Viruses9 citations Open access
Semantic Scholar
Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop
U. Thisyakorn, M. R. Capeding, D. Goh, S. R. Hadinegoro +4 more
2014Expert Review of Vaccines9 citations
Semantic Scholar
Proceedings of the 6th Asia Dengue Summit, June 2023
N. Srisawat, D. J. Gubler, T. Pangestu, Umaporn Limothai +11 more
2024PLoS Neglected Tropical Diseases8 citations Open access
Semantic Scholar
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority study.
D. Coronel-MartÍnez, Juliana Park, Eduardo López-Medina, M. R. Capeding +13 more
2022Lancet. Infectious Diseases (Print)8 citations
Semantic Scholar
Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
M. R. Capeding, E. Alberto, Jodi Feser, Jessica Mooney +8 more
2020Vaccine: X8 citations Open access
Semantic Scholar
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: randomised, active-controlled, observer-blinded, phase 3 trial
J. Song, W. Choi, Eun Jin Kim, Jung Yeon Heo +57 more
2023medRxiv7 citations Open access
Semantic Scholar
Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines
M. R. Capeding, M. L. A. Gonzales, M. Dhingra, N. D'Cor +4 more
2017Human Vaccines & Immunotherapeutics7 citations Open access
Semantic Scholar
Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study.
M. R. Capeding, C. Jica, A. Macura-Biegun, M. Rauscher +1 more
2014Vaccine7 citations Open access
Semantic Scholar
Proceedings of the 5th Asia Dengue Summit
N. Srisawat, D. Gubler, T. Pangestu, U. Thisyakorn +10 more
2023Tropical Medicine and Infectious Disease5 citations Open access
Semantic Scholar
A Narrative Review of Pneumococcal Disease in Children in the Philippines
A. Gamil, Miriam Y. Lalas, M. R. Capeding, A. Ong-Lim +2 more
2021Infectious Disease and Therapy5 citations Open access
Semantic Scholar
Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial.
M. R. Capeding, Josefina Cadorna-Carlos, May Book-Montellano, E. Ortiz
2008Bulletin of the World Health Organization5 citations
Semantic Scholar
Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
M. R. Capeding, E. Alberto, Amanda M. G. Versteilen, M. Rauscher +2 more
2016International Journal of Infectious Diseases4 citations Open access
Semantic Scholar
Proceedings of the 7th Asia Dengue Summit, June 2024
Z. Ismail, D. J. Gubler, T. Pangestu, U. Thisyakorn +9 more
2025Vaccines2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Bouckenooghe×12
Invite
A. Bouckenooghe — researcher profile on SciRah
E. Alberto×9
Invite
E. Alberto — researcher profile on SciRah
S. R. Hadinegoro×8
Invite
S. R. Hadinegoro — researcher profile on SciRah
T. Chotpitayasunondh×6
Invite
T. Chotpitayasunondh — researcher profile on SciRah

×6

Invite

Thelma M. Laot — researcher profile on SciRah

Invite

J. Ryu — researcher profile on SciRah

Invite

Hun Kim — researcher profile on SciRah

Invite

S. Yoksan — researcher profile on SciRah

S. R. Hadinegoro×5

Invite

S. R. Hadinegoro — researcher profile on SciRah

Invite

C. Frago — researcher profile on SciRah

Invite

F. Noriega — researcher profile on SciRah

Invite

T. Wartel — researcher profile on SciRah